Podolsky DK. Inflammatory bowel disease. N Engl J Med. 2002;347:417–29.
Article
CAS
PubMed
Google Scholar
David JR. Delayed hypersensitivity in vitro: its mediation by cell-free substances formed by lymphoid cell–antigen interaction. Proc Natl Acad Sci U S A. 1966;56:72–7.
Article
CAS
PubMed
PubMed Central
Google Scholar
Lue H, Kleemann R, Calandra T, Roger T, Bernhagen J. Macrophage migration inhibitory factor (MIF): mechanisms of action and role in disease. Microb Infect. 2002;4:449–60.
Article
CAS
Google Scholar
Murakami H, Akbar SM, Matsui H, Horiike N, Onji M. Macrophage migration inhibitory factor activates antigen-presenting dendritic cells and induces inflammatory cytokines in ulcerative colitis. Clin Exp Immunol. 2002;128:504–10.
Article
CAS
PubMed
PubMed Central
Google Scholar
Ishiguro Y, Yamagata K, Sakuraba H, Munakata A, Nakane A, Morita T, et al. Macrophage migration inhibitory factor and activator protein-1 in ulcerative colitis. Ann N Y Acad Sci. 2004;1029:348–9.
Article
CAS
PubMed
Google Scholar
Renner P, Roger T, Calandra T. Macrophage migration inhibitory factor: gene polymorphisms and susceptibility to inflammatory diseases. Clin Infect Dis. 2005;41(Suppl 7):S513–9.
Article
CAS
PubMed
Google Scholar
Shiroeda H, Tahara T, Nakamura M, Shibata T, Nomura T, Yamada H, et al. Association between functional promoter polymorphisms of macrophage migration inhibitory factor (MIF) gene and ulcerative colitis in Japan. Cytokine. 2010;51:173–7.
Article
CAS
PubMed
Google Scholar
Zhang H, Ma L, Dong LQ, Shu C, Xu JL. Association of the macrophage migration inhibitory factor gene −173G/C polymorphism with inflammatory bowel disease: a meta-analysis of 4296 subjects. Gene. 2013;526:228–31.
Article
CAS
PubMed
Google Scholar
Shen Y, Guo S, Yang T, Jia L, Chen L, An J, et al. The -173 G/C polymorphism of the MIF gene and inflammatory bowel disease risk: a meta-analysis. Int J Mol Sci. 2013;14:11392–401.
Article
PubMed
PubMed Central
CAS
Google Scholar
Trigo-Vicente C, Gimeno-Ballester V, García-López S, López-Del VA. Systematic review and network meta-analysis of treatment for moderate-to-severe ulcerative colitis. Int J Clin Pharm. 2018;40:1411–9.
Article
PubMed
Google Scholar
Ekbom A, Helmick C, Zack M, Adami HO. Ulcerative colitis and colorectal cancer. A population-based study. N Engl J Med. 1990;323:1228–33.
Article
CAS
PubMed
Google Scholar
Eaden JA, Abrams KR, Mayberry JF. The risk of colorectal cancer in ulcerative colitis: a meta-analysis. Gut. 2001;48:526–35.
Article
CAS
PubMed
PubMed Central
Google Scholar
Askling J, Dickman PW, Karlen P, Broström O, Lapidus A, Löfberg R, et al. Family history as a risk factor for colorectal cancer in inflammatory bowel disease. Gastroenterology. 2001;120:1356–62.
Article
CAS
PubMed
Google Scholar
Nuako KW, Ahlquist DA, Mahoney DW, Schaid DJ, Siems DM, Lindor NM. Familial predisposition for colorectal cancer in chronic ulcerative colitis: a case-control study. Gastroenterology. 1998;115:1079–83.
Article
CAS
PubMed
Google Scholar
Rutter MD, Saunders BP, Wilkinson KH, Rumbles S, Schofield G, Kamm MA, et al. Cancer surveillance in longstanding ulcerative colitis: endoscopic appearances help predict cancer risk. Gut. 2004;53:1813–6.
Article
CAS
PubMed
PubMed Central
Google Scholar
Jones PA, Baylin SB. The fundamental role of epigenetic events in cancer. Nat Rev Genet. 2002;3:415–28.
Article
CAS
PubMed
Google Scholar
Issa JP, Ottaviano YL, Celano P, Hamilton SR, Davidson NE, Baylin SB. Methylation of the oestrogen receptor CpG island links ageing and neoplasia in human colon. Nat Genet. 1994;4:536–40.
Article
Google Scholar
Tahara T, Arisawa T. DNA methylation as a molecular biomarker in gastric cancer. Epigenomics. 2015;7:475–86.
Article
CAS
PubMed
Google Scholar
Issa JP, Ahuja N, Toyota M, Bronner MP, Brentnall TA. Accelerated age-related CpG island methylation in ulcerative colitis. Cancer Res. 2001;61:3573–7.
CAS
PubMed
Google Scholar
Tahara T, Shibata T, Nakamura M, Okubo M, Yamashita H, Yoshioka D, et al. Association between polymorphisms in the XRCC1 and GST genes, and CpG island methylation status in colonic mucosa in ulcerative colitis. Virchows Arch. 2011;458:205–11.
Article
CAS
PubMed
Google Scholar
Podolsky DK. Inflammatory bowel disease (1). N Engl J Med. 1991;325:928–37.
Article
CAS
PubMed
Google Scholar
Langholz E, Munkholm P, Davidsen M, Binder V. Course of ulcerative colitis: analysis of changes in disease activity over years. Gastroenterology. 1994;107:3–11.
Article
CAS
PubMed
Google Scholar
Arisawa T, Tahara T, Shibata T, Nagasaka M, Nakamura M, Kamiya Y, et al. The influence of promoter polymorphism of nuclear factor-erythroid 2-related factor 2 gene on the aberrant DNA methylation in gastric epithelium. Oncol Rep. 2008;19:211–6.
CAS
PubMed
Google Scholar
Swope MD, Lolis E. Macrophage migration inhibitory factor: cytokine, hormone, or enzyme? Rev Physiol Biochem Pharmacol. 1999;139:1–32.
Article
CAS
PubMed
Google Scholar
Leech M, Metz C, Hall P, Hutchinson P, Ganis K, Smith M, et al. Macrophage migration inhibitory factor in rheumatoid arthritis: evidence of proinflammatory function and regulation by glucocorticoids. Arthritis Rheum. 1999;42:1601–8.
Article
CAS
PubMed
Google Scholar
Bernhagen J, Calandra T, Bucala R. The emerging role of MIF in septic shock and infection. Biotherapy. 1995;8:123–7.
Article
Google Scholar
Murakami H, Akbar SM, Matsui H, Onji M. Macrophage migration inhibitory factor in the sera and at the colonic mucosa in patients with ulcerative colitis: clinical implications and pathogenic significance. Eur J Clin Investig. 2001;31:337–43.
Article
CAS
Google Scholar
Donn R, Alourfi Z, De Benedetti F, Meazza C, Zeggini E, Lunt M, et al. Mutation screening of the macrophage migration inhibitory factor gene: positive association of a functional polymorphism of macrophage migration inhibitory factor with juvenile idiopathic arthritis. Arthritis Rheum. 2002;46:2402–9.
Article
CAS
PubMed
Google Scholar
Amoli MM, Donn RP, Thomson W, Hajeer AH, Garcia-Porrua C, Lueiro M, et al. Macrophage migration inhibitory factor gene polymorphism is associated with sarcoidosis in biopsy proven erythema nodosum. J Rheumatol. 2002;29:1671–3.
CAS
PubMed
Google Scholar
Arisawa T, Tahara T, Shibata T, Nagasaka M, Nakamura M, Kamiya Y, et al. Functional polymorphisms in the promoter region of macrophage migration inhibitory factor and chronic gastritis. Int J Mol Med. 2007;20:539–44.
CAS
PubMed
Google Scholar
Arisawa T, Tahara T, Shibata T, Nagasaka M, Nakamura M, Kamiya Y, et al. Functional promoter polymorphisms of the macrophage migration inhibitory factor gene in gastric carcinogenesis. Oncol Rep. 2008;19:223–8.
CAS
PubMed
Google Scholar
Nohara H, Okayama N, Inoue N, Koike Y, Fujimura K, Suehiro Y, et al. Association of the -173G/C polymorphism of the macrophage migration inhibitory factor gene with ulcerative colitis. J Gastroenterol. 2004;393:242–6.
Article
CAS
Google Scholar
Rizos H, Darmanian AP, Mann GJ, Kefford RF. Two arginine rich domains in the p14ARF tumour suppressor mediate nucleolar localization. Oncogene. 2000;19:2978–85.
Article
CAS
PubMed
Google Scholar
Tannapfel A, Busse C, Weinans L, Benicke M, Katalinic A, Geissler F, et al. INK4a-ARF alterations and p53 mutations in hepatocellular carcinomas. Oncogene. 2001;20:7104–9.
Article
CAS
PubMed
Google Scholar
Poi MJ, Knobloch TJ, Li J. Deletion of RDINK4/ARF enhancer: a novel mutation to “inactivate” the INK4-ARF locus. DNA Repair (Amst). 2017;57:50–5.
Article
CAS
Google Scholar
Shames DS, Minna JD, Gazdar AF. DNA methylation in health, disease, and cancer. Curr Mol Med. 2007;7:85–102.
Article
CAS
PubMed
Google Scholar
Sato F, Harpaz N, Shibata D, Xu Y, Yin J, Mori Y, et al. Hypermethylation of the p14(ARF) gene in ulcerative colitis-associated colorectal carcinogenesis. Cancer Res. 2002;62:1148–51.
CAS
PubMed
Google Scholar
Tahara T, Hirata I, Nakano N, Tahara S, Horiguchi N, Kawamura T, et al. Potential link between Fusobacterium enrichment and DNA methylation accumulation in the inflammatory colonic mucosa in ulcerative colitis. Oncotarget. 2017;8:61917–26.
Article
PubMed
PubMed Central
Google Scholar
Emmett RA, Davidson KL, Gould NJ, Arasaradnam RP. DNA methylation patterns in ulcerative colitis-associated cancer: a systematic review. Epigenomics. 2017;9:1029–42.
Article
CAS
PubMed
Google Scholar
Hibi K, Nakayama H, Koike M, Kasai Y, Ito K, Akiyama S, et al. Colorectal cancers with both p16 and p14 methylation show invasive characteristics. Jpn J Cancer Res. 2002;93:883–7.
Article
CAS
PubMed
PubMed Central
Google Scholar
Rogler G. Inflammatory bowel disease cancer risk, detection and surveillance. Dig Dis. 2012;30(Suppl 2):48–54.
Article
PubMed
Google Scholar
Tahara T, Hirata I, Nakano N, Nagasaka M, Nakagawa Y, Shibata T, et al. Comprehensive DNA methylation profiling of inflammatory mucosa in ulcerative colitis. Inflamm Bowel Dis. 2017;23:165–73.
Article
PubMed
Google Scholar
Tahara T, Shibata T, Nakamura M, Okubo M, Yamashita H, Yoshioka D, et al. Host genetic factors, related to inflammatory response, influence the CpG island methylation status in colonic mucosa in ulcerative colitis. Anticancer Res. 2011;31:933–8.
CAS
PubMed
Google Scholar